INTRODUCTION
When Abel and associates first described "vividiffusion" in 1913, they used sodium salicylate as a test substance to measure the amount of solute removed from blood (1). With the introduction of dialysis in clinical medicine its potential applications in the treatment of poisoning and drug overdose were recognized and a long list of "dialyzable" substances was generated. Subsequent experience, however, led to the realization that extracorporeal treatment was effective in only a small minority of poisoned patients (2).
Radiographic contrast media are of interest in this regard as they are used extensively in modern medicine and are excreted by the kidneys. Delayed excretion of these compounds in patients with impaired renal function has long been a matter of concern, and this has led to nephrologists being asked to perform dialysis immediately following radiographic procedures that require intravenous contrast. In order to make a rational decision in these circumstances two questions need to be answered: first, is hemodialysis an effective way of removing contrast media from the body and, secondly, is there any benefit in doing so? The answer to these questions involves a consideration of the chemical nature of contrast media, their expected untoward effects, and some general principles of dialysis.
Contrast media
Conventional radiographic contrast media are organic iodides with relatively high osmolality and molecular weights of 600-1650 daltons. Iodinated contrast media are water soluble with low lipid solubility and protein binding and are distributed throughout the extracellular fluid (3,4). These compounds are not taken up by the cells except in specialized tissues such as the renal tubules. Clearance is by glomerular filtration with little or no excretion through extrarenal routes in patients with normal kidneys. The halflife of intravenous contrast media is: 1-2 hours in normal subjects, but this may be prolonged to 15-30 hours in the anephric state, and there are reports of extreme prolongation to 72 hours in some patients (5,6). In some cases of mild renal dysfunction, CT scanning after 24 hours has shown retention of contrast material within the kidney (7).
Persistence of contrast material within the body is thus to be expected in all patients with renal disease, and one would expect that the growing population of functionally anephric patients on dialysis would be at particular risk in this regard. Whether this is harmful to the patient or not requires some consideration of the side-effects of radiographic contrast media.
A recent review lists these reactions as minor (flushing, nausea, pruritis, vomiting, urticara), occurring in 5-15% of patients; intermediate (hypotension and bronchospasm) in 1-2%; and severe or life-threatening in 0.2-0.06% (4). The important point to remember about these reactions is that they usually occur within 5-20 minutes of intravenous administraton of contrast. Treatment needs to be started immediately and since it is not possible to start a patient on dialysis for a matter of hours, it is unlikely that extracorporeal removal of contrast will be of any use. A possible exception to this is acute pulmonary edema during radiographic procedures in a patient with end stage renal disease. In such cases it is impossible to tell if this complication is due to altered vascular permeability or fluid overload, and dialysis may be considered after the initial resuscitation measures (including intubation if necessary) have been done.
In addition to the idiosyncratic reactions described above, contrast media have organ specific toxicity, the renal effects being most germane to this discussion. Contrast nephropathy is usually evident within 24 hours and lasts, on the average, 3-5 days. Well established risk factors are volume depletion, diabetes mellitus, and multiple myeloma. However, the single most important predisposing factor is pre-existing renal insufficiency irrespective of the underlying disease. Pre-treatment of patients at risk with intravenous fluids (8) and acetylcysteine (9) has been shown to reduce the incidence of contrast nephropathy. Dialysis shortly after the procedure to remove the accumulated contrast has also been advocated as a prophylactic measure. This is not an undertaking to be embarked upon lightly as the patients rarely have an access for dialysis and the procedure itself has potential complications, particularly hypotension and blood loss which could easily make the situation worse and not better. In purely practical terms it is not always easy to arrange for an acute hemodialysis at short notice.
Dialytic removal
Removal of solute by hemodialysis occurs predominantly by diffusion with a lesser contribution due to bulk flow of fluid across the membrane. Contrast media have some properties favoring rapid transfer across the dialytic membrane, i.e. water solubility, low protein binding, and low intracellular penetration, but the removal rate is limited by their molecular weight (10) which approximates that of the hypothetical "middle molecules" and is considerably higher than that of readily dialyzed molecules such as urea and creatinine.
Early studies suggested that dialytic removal of contrast material was inefficient with clearance values of the order of 30-50 ml/minute (11) . However, these studies were performed utilizing dialyzers with cuprophane membranes of low permeability. Since then there have been numerous studies of the effects of dialysis on serum levels of radiographic contrast media utilizing a wide variety of membranes and dialyzer configurations and including both older (ionic) and more modern (nonionic) contrast media (5, [11] [12] [13] [14] [15] [16] . Given the wide variation in the timing of dialysis after the procedure, length of dialysis and choice of dialyzer, it is not possible to make comparisons of these studies. However, there is a striking trend towards increasing the efficiency of dialysis for removing contrast media, clearance values of 80-120 ml/minute being frequently observed. Thus it is evident that with modern dialyzing techniques a substantial decrease in the body burden of contrast can be achieved and some authors have reported a decrease in total iodine content of 40-70%.
This improvement in efficiency reflects the use of more permeable membranes, large surface area dialyzers, and higher blood flow.
Some data is available comparing the efficiency of semi-synthetic and synthetic dialysis membranes in this setting. In vitro studies indicated that polyacrilonitrile was superior to cuprophane (14) and one in vivo study showed that polysulphone was superior to cuprophane (16) .
Post-contrast dialysis
Dialysis immediately after radiographic contrast studies has been recommended for two groups of patients -those on chronic hemodialysis and those at high risk for contrast nephropathy (15) .
In patients on maintenance dialysis, the half-life of iodinated contrast media is increased several-fold and this accumulation has been considered dangerous for several reasons. Firstly, these agents are hyperosmolar and cause a shift of fluid into the extracellular space. Conceivably, this could lead to acute pulmonary edema in patients on dialysis, although no such cases have actually been reported. Secondly, it was feared that the patient with end-stage renal disease was more likely to develop side-effects from contrast media because of the prolonged exposure to these agents. Again, there is virtually no data to confirm this although a single case report documents neurological symptoms in a dialysis patient given a massive dye load (17) .
Two studies have examined the effects of nonionic contrast media in chronic hemodialysis patients (18, 19) . The first study included 22 patients and the incidence of side-effects was observed over the next five days. The authors found that the patients here had no more sideeffects than those without renal failure. Similar conclusions were reached in the second study which included 10 patients also given nonionic contrast media. None of these patients required dialysis before the next scheduled session.
In patients with impaired renal function the risks of contrast nephropathy are known to be much increased. In a study of 13 patients with serum creatinine 214-657 µmol/l, dialysis was done within 1-18 hours of the procedure and no patient had a rise in serum creatinine (15) . The authors conclude that dialysis is helpful in preventing contrast nephropathy. However, the absence of a control group makes these findings difficult to interpret. A controlled study of 30 patients (serum creatinine 212±14 µmol/l) has been reported recently (20) . Patients received a nonionic, low osmolar agent and were randomly assigned to dialysis or no dialysis immediately after the radiographic study. The rate of contrast nephropathy was similar in the two groups. The authors point out that the renal effects of contrast probably occur within 30 minutes of injection and removal by dialysis is unlikely to be protective. In addition, although 1/3 of the contrast load was removed by dialysis, this is based on blood levels. It is known that tissue concentrations remain high for weeks after these agents have disappeared from the blood stream. Since contrast media are concentrated in the kidneys it is likely that tissue levels in these organs remain high despite the marked reduction in blood levels by dialysis.
CONCLUSIONS
Delayed excretion of iodinated media in renal failure has led to concerns about increased toxicity in such patients after radiographic studies which require intravenous contrast. With modern methods of hemodialysis, it is possible to remove substantial amounts of contrast. The total amount removed may be 1/3 -2/3 of the dye load using high blood flows and more permeable membranes. However, hemodialysis itself is not without hazards and it may be difficult to schedule a treatment immediately after the radiographic procedure.
The limited data available does not support the use of early dialysis in this setting. Thus, patients with end stage renal disease do not have an increased incidence of side-effects following intravenous contrast and can wait until their next scheduled dialysis.
Moreover, although patients with renal insufficiency are at increased risk of contrast nephrotoxicity, the risk is not decreased by post-procedure dialysis. At present, dialytic removal of contrast material is not recommended.
